Latest filing published 02 Jul 2025 for SpringWorks Therapeutics, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Daniel Pichl on record concern SpringWorks Therapeutics, Inc., in the capacity of senior executive. The record holds 29 filings, for trades running from 7 January 2021 to 1 July 2025.
The open-market record consists of 9 sales worth €3.4M, with no purchase. Other entries cover 14 share grants and 5 option exercises. So far in 2025, the count stands at no purchases and 3 sales.
The latest filing, published on 2 July 2025, reports a transaction in SpringWorks Therapeutics, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations